Sandra M Herrmann
Overview
Explore the profile of Sandra M Herrmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa E Silva V, Xiong F, Mantz L, Sise M, Herrmann S, Kitchlu A
Kidney360
. 2025 Feb;
PMID: 39992722
Accurate assessment of glomerular filtration rate (GFR) is key in patients with cancer, to guide drug eligibility, adjust dosing of systemic therapy, and minimize the risks of undertreatment and systemic...
2.
Mohan A, Barbir E, Hernandez L, Leung N, Herrmann S
Clin Kidney J
. 2025 Feb;
18(2):sfae425.
PMID: 39974847
We report a case of acute interstitial nephritis (AIN) in a 68-year-old male with squamous cell carcinoma (SCC) and relapsed/refractory multiple myeloma (RRMM) who developed acute kidney injury (AKI) shortly...
3.
Titan S, Lieske J, Meeusen J, Thorson S, Lin Y, Nowakowski G, et al.
Clin J Am Soc Nephrol
. 2025 Jan;
20(3):358-366.
PMID: 39874103
No abstract available.
4.
Charkviani M, Brochero M, Mohan A, Vaughan L, Sandahl T, De Menezes Silva Corrae A, et al.
Nephrol Dial Transplant
. 2025 Jan;
PMID: 39805729
Background And Hypothesis: Teclistamab, a novel bispecific monoclonal antibody targeting CD3 and B-cell maturation antigen (BCMA), and chimeric antigen receptor T-cell (CAR-T) therapy are promising options for treating relapsed/refractory multiple...
5.
Gupta S, Kaunfer S, Chen K, Dias J, Vijayan A, Rajasekaran A, et al.
Blood
. 2025 Jan;
PMID: 39760780
High-dose methotrexate (MTX) results in high rates of acute kidney injury (AKI), neutropenia, and hepatotoxicity. Glucarpidase is a recombinant enzyme that cleaves MTX, but clinical data supporting its use are...
6.
Barbir E, Mohan A, Koirala P, Gutierrez L, Giesen C, Lieske J, et al.
Nephrol Dial Transplant
. 2024 Nov;
40(3):602-604.
PMID: 39516049
No abstract available.
7.
Herrmann S, Abudayyeh A, Gupta S, Gudsoorkar P, Klomjit N, Motwani S, et al.
Kidney Int
. 2024 Oct;
107(1):21-32.
PMID: 39455026
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer and are now the backbone of therapy for several malignancies. However, ICIs can cause a spectrum of kidney immune-related adverse...
8.
Kitchlu A, Costa E Silva V, Anand S, Kala J, Abudayyeh A, Inker L, et al.
Clin J Am Soc Nephrol
. 2024 Sep;
19(8):1073-1077.
PMID: 39316409
No abstract available.
9.
Barbir E, Kitchlu A, Herrmann S
Nephrol Dial Transplant
. 2024 Aug;
39(11):1785-1798.
PMID: 39138117
Over the last 13 years, the use of immune checkpoint inhibitor (ICI) therapy has grown remarkably, owing to their unprecedented anti-tumor efficacy in certain tumor groups. With increased use of...
10.
Gupta S, Green-Lingren O, Bhimaniya S, Krokhmal A, Jacene H, Ostermann M, et al.
J Clin Invest
. 2024 Aug;
134(18).
PMID: 39115940
No abstract available.